Yentl syndrome

Yentl Syndrome is a term coined in the medical field to describe a bias in the treatment and diagnosis of heart disease in women. The term was first introduced by Dr. Bernadine Healy in 1991, referencing the movie Yentl where a woman had to disguise herself as a man to receive the same treatment as her male counterparts.

Overview

Yentl Syndrome is a phenomenon where women with heart disease are not diagnosed or treated as aggressively as men because their symptoms are often different and less recognizable. This can lead to a delay in treatment, which can result in more severe outcomes for women.

History

The term was first used by Dr. Bernadine Healy, the first woman to head the National Institutes of Health, in a 1991 article in the New England Journal of Medicine. She used the term to highlight the disparity in treatment between men and women when it comes to heart disease.

Symptoms and Diagnosis

Women with heart disease often present with different symptoms than men. While men often experience chest pain, women may experience symptoms such as fatigue, shortness of breath, and nausea. These symptoms are often overlooked or misdiagnosed, leading to a delay in treatment.

Treatment

Once diagnosed, women with heart disease are often not treated as aggressively as men. This can include less aggressive use of procedures such as angioplasty and bypass surgery. This disparity in treatment can lead to worse outcomes for women.

Impact

The impact of Yentl Syndrome is significant. It contributes to the higher mortality rates seen in women with heart disease compared to men. It also highlights the need for more research and education on the unique symptoms and treatment needs of women with heart disease.

See Also

• Gender disparities in health
• Heart disease
• Bernadine Healy

Yentl syndrome Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.